Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
01/03/2007 | CN1890216A Carboxamide derivatives |
01/03/2007 | CN1890215A Inhibitors of hepatitis c virus ns3/ns4a serine protease |
01/03/2007 | CN1890208A Opioid receptor antagonists |
01/03/2007 | CN1889951A Substituted benzazoles and methods of their use as inhibitors of RAF kinase |
01/03/2007 | CN1887883A V-shaped conjugated light-absorbing organic salt compound and its use |
01/03/2007 | CN1293076C Activator for peroxisome proliferator-activated receptor delta |
01/03/2007 | CN1293075C Indole and 2,3-indoline derivative, their preparation and application |
01/03/2007 | CN1293074C Arylindenopyridines with PDE inhibiting activity |
01/03/2007 | CN1293073C Teterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-Hydroxytryptamine-6-ligands |
01/03/2007 | CN1293072C Heterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
01/03/2007 | CN1293058C O-cyclopropyl-carboxanilides and their use as fungicides |
01/03/2007 | CN1293057C Ethylenediamine derivatives |
01/03/2007 | CN1293056C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
01/03/2007 | CN1293053C 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders |
01/03/2007 | CN1292798C Ethylenedicysteine (EC)-drug conjugates |
01/02/2007 | US7157596 Inhibitors of serine protease activity of matriptase or MTSP1 |
01/02/2007 | US7157580 Aminopyrimidine and aminopyridine anti-inflammation agents |
01/02/2007 | US7157489 HIV protease inhibitors |
01/02/2007 | US7157486 For therapy and prophylaxis of hepatitis C virus (HCV) infection |
01/02/2007 | US7157474 Mixing at least one nonaqueous, pharmaceutically acceptable solvent and a taxane compound |
01/02/2007 | US7157470 For use as anticoagulant agents for therapy of thromboembolic disorders |
01/02/2007 | US7157469 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
01/02/2007 | US7157464 Substituted piperazines |
01/02/2007 | US7157456 Anticoagulates for treating cardiovascular disorders, such as myocardial infarct, angina pectoris, restenoses after angioplasty, bypass, stroke; treatment of atherosclerosis, arthritis, Alzheimer's disease or cancer |
01/02/2007 | US7157455 4-Aminopyrimidine-5-one derivatives |
01/02/2007 | US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
01/02/2007 | CA2344350C 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines |
01/02/2007 | CA2177602C N-substituted azabicycloalkane derivatives, their preparation and use |
01/02/2007 | CA2153419C Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
12/28/2006 | WO2006138218A1 Biphenyl compounds useful as muscarinic receptor antagonists |
12/28/2006 | WO2006137485A1 Novel nitrogenated heterocyclic compound and salt thereof |
12/28/2006 | WO2006136924A1 Histamine-3 receptor antagonists |
12/28/2006 | WO2006136552A2 Process for the production of intermadiates for the preparation of tricyclic benzimidazoles |
12/28/2006 | WO2006136305A1 SUBSTITUTED PYRR0LIDIN-2-0NES , PIPERIDIN-2-0NES AND ISOTHIAZOLIDINE-1, 1-DIOXIDES, THEIR USE AS KVl .5 POTASSIUM CHANNEL BLOCKERS AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM |
12/28/2006 | WO2006098918B1 Substituted gamma lactams as therapeutic agents |
12/28/2006 | WO2006060381A3 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
12/28/2006 | WO2006058648A3 Biaryloxymethylarene carboxylic acids |
12/28/2006 | US20060293500 Thiophene-containing compound and polymer thereof |
12/28/2006 | US20060293379 chemoattractant cytokine receptor 2 (CCR2) antagonists such as {4-[(3-bromo-8,9-dihydro-7H-benzocycloheptene-6-carbonyl)-amino]-benzyl}-cyclohexyl-dimethyl-ammonium iodide, useful in preventing, treating or ameliorating CCR2 mediated inflammatory syndromes, disorders or diseases; antiinflammatory agents |
12/28/2006 | US20060293375 Crystal of 4-(1-((4-methylbenzothiophen-3-yl)methyl)benzimidazol-2-ylthio)butanoic acid; has chymase inhibitory activity in living body and can be used as a preventive and/or remedy for inflammatory diseases, allergic diseases, respiratory tract diseases, circulatory diseases, or bone metabolic diseases |
12/28/2006 | US20060293373 Gamma-secretase inhibitors |
12/28/2006 | US20060293360 4-(2-Phenyloxyphenyl)-piperidine or-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
12/28/2006 | US20060293354 Pyrimidine derivatives and their use as CB2 modulators |
12/28/2006 | US20060293353 Matrix metalloproteinase inhibitors |
12/28/2006 | US20060293343 Pyrimidine derivatives |
12/28/2006 | US20060293334 Nitrogen-containing heteroaryl compounds having inhibitory activity against HIV integrase |
12/28/2006 | US20060293332 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
12/28/2006 | US20060293326 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
12/28/2006 | US20060293314 4- Piridinylmethylsulphonamide derivatives as fungicidal plant protein agents |
12/28/2006 | US20060293306 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
12/28/2006 | US20060293300 New substituted thiophene carboxamides, process for their preparation and their use as medicaments |
12/28/2006 | US20060293299 3-((1S)-1-{1-[(S)-(3-cyanophenyl)(4-cyanophenyl)methyl]azetidin-3-yl}-2-fluoro-2-methylpropyl)-5-fluorobenzonitrile and its salts; antagonists and inverse agonists of the Cannabinoid-1 receptor |
12/28/2006 | CA2612112A1 Process for the production of intermediates for the preparation of tricyclic benzimidazoles |
12/28/2006 | CA2610326A1 Substituted pyrr0lidin-2-0nes , piperidin-2-0nes and isothiazolidine-1, 1-dioxides, their use as kv1.5 potassium channel blockers and pharmaceutical preparations comprising them |
12/27/2006 | EP1736474A1 Piperidine derivative |
12/27/2006 | EP1736471A1 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinolines |
12/27/2006 | EP1736468A2 Isatin derivatives with neurotrophic activity useful in the treatment of diseases mediated by the nerve growth factor (NGF) activation |
12/27/2006 | EP1735319A1 Inhibitors of histone deacetylase |
12/27/2006 | EP1735307A1 Inhibitors of iap |
12/27/2006 | EP1735302A1 4-amino-piperidine derivatives as monoamine uptake inhibitors |
12/27/2006 | EP1735301A1 Pyridine derivatives as cannabinoid receptor modulators |
12/27/2006 | EP1735287A1 Therapeutic agents |
12/27/2006 | EP1735286A1 Tetrahydro-indazole cannabinoid modulators |
12/27/2006 | EP1734951A2 Diphenyl-indol-2-on compounds and their use in the treatment of cancer |
12/27/2006 | EP1471786B1 Microbiocidal n-phenyl-n- 4-(4-pyridyl)-2-pyrimidin-2-yl|-amine derivatives |
12/27/2006 | EP1299374B1 Novel non-psychotropic cannabinoids |
12/27/2006 | EP1187826B1 Heterocyclic derivatives useful as anticancer agents |
12/27/2006 | EP1021410B1 Prostaglandin agonists and their use to treat bone disorders |
12/27/2006 | CN1887033A Charge-transporting organic material containing compound having 1,4-dithiin ring |
12/27/2006 | CN1886402A pyrimidin-2-amine derivates and their use as a2b adenosine receptor antagonists |
12/27/2006 | CN1886399A 喹唑啉衍生物 Quinazoline derivatives |
12/27/2006 | CN1886397A 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3) |
12/27/2006 | CN1886391A Tetronic and tetramic acids as inhibitors of beta-secrease |
12/27/2006 | CN1886381A Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides |
12/27/2006 | CN1886378A 1,4-disubstituted isoquinilone derivatives as RAF-kinase inhibitors useful for the treatment of proliferative diseases |
12/27/2006 | CN1884266A Aromatic-cyclo and heterocyclo acylmethyl imidazole salts compound and method for preparing same |
12/27/2006 | CN1291983C Luminescent element material and luminescent element comprising the same |
12/27/2006 | CN1291720C Non-sedating barbituric acid derivatives |
12/26/2006 | US7153968 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease, eosinophilic granuloma, psoriasis and other benign or malignant proliferative skin diseases, endotoxic shock, laminitis in horses, colic in horses, septic shock, ulcerative colitis, Crohn's disease, reperfusion injury |
12/26/2006 | US7153959 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis |
12/26/2006 | US7153889 Alzheimer's disease; antihistamines; attention deficit disorders; hyperactivity; bipolar disorders; cognition activators; psychological disorders; anticancer agents; antidepressants; antiepileptic agents; gastrointestinal disorders ; analgesics |
12/26/2006 | US7153884 C-2′ methylated derivatives of paclitaxel for use as antitumour agents |
12/26/2006 | US7153883 Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds |
12/26/2006 | US7153868 N-(3-(4-substituted-1-piperidinyl)-1-phenylpropyl) substituted sulfonamides as NK-3 receptor antagonists |
12/26/2006 | US7153857 antiinflammatory agents; antiarthritic agents; anticancer agents |
12/26/2006 | US7153856 Orally administering N-(2-chloro-6-methylphenyl)-2-[4-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-6-ylamino]thiazole-5-carboxamide for treating cancer |
12/26/2006 | US7153848 13-C5-7-cycloalkylindolo[2.1-a][2]benzazepine derivatives; e.g., 3-[3-[3-[1-[[(13-cyclohexyl-7H-indolo[2,1-a][2]benzazepin-10-yl)carbonyl]amino]cyclopentyl]-1,2,4-oxadiazol-5-yl]phenyl]-(2E)-2-propenoic acid |
12/21/2006 | WO2006135828A2 Trisubstituted amines as phosphodiesterase 4 inhibitors |
12/21/2006 | WO2006135826A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
12/21/2006 | WO2006135705A1 Process for producing cyano substituted arene boranes and compounds |
12/21/2006 | WO2006134989A1 Nitrogenated heterocyclic compound |
12/21/2006 | WO2006134481A1 Inhibitors of 11-beta hydroxysteroid dehydrogenase type 1 |
12/21/2006 | WO2006134460A1 Chromane substituted benzimidazole derivatives as acid pump antagonists |
12/21/2006 | WO2006134163A2 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
12/21/2006 | WO2006133926A1 Pyrazole derivates as cannabinoid receptor modulators |
12/21/2006 | WO2006133821A1 Tetrahydroquinolines used in the form of modulators of mitotic motor-proteins eg5 |
12/21/2006 | WO2006083673A3 Pyridine derivatives useful as inhibitors of c-jun n-terminal kinases |
12/21/2006 | WO2005047244A3 Inhibition of fgfr3 and treatment of multiple myeloma |
12/21/2006 | WO2005032468A3 Monocyclic and bicyclic lactams as factor xa inhibitors |
12/21/2006 | US20060287536 Phenyl-thiophene type vitamin d receptor modulators |